Grant: Canada Postdoctoral Research Award (CPRA) program
University of British Columbia
$140,000.00
Measuring the impact of pharmacist minor ailments prescribing policy on health system burden
EF 2025-26
Résumé
The current challenges across the country in accessing a family physician have resulted in overcrowded emergency departments and delays in care. The new Pharmacist Prescribing for Minor Ailments and Contraception policy (PPMAC) in British Columbia (BC) was implemented to ease pressures on the province's healthcare system. However, even though similar policies have been in use for about ten years in some provinces, the impact of these services on the health system has never been measured. The policy may also improve equitable access to care, but prior studies have suggested that individuals experiencing socioeconomic disadvantages have less access to pharmacist services. This may worsen pre-existing health inequalities among these disadvantaged groups, which include women, rural residents, visible minority groups, lower income individuals, among others. As such, it would be important to understand 1) what the impact of the PPMAC policy is on health system burden and 2) if the level of impact differs across socioeconomic groups.
This research will describe changes in medication use, physician visits, and emergency room visits after PPMAC was implemented to understand how the policy is impacting the health system. The impact will be assessed in the three most commonly treated PPMAC conditions - contraception, urinary tract infections, and pink eye. The changes will be described by each condition for the overall population, then for various socioeconomic groups to understand if the level of impact is different across communities. We will check these findings with another study to make sure that other efforts to improve care access following the COVID-19 pandemic did not affect the results.
Findings from this work will allow policymakers in BC and other provinces to make informed decision on whether changes to pharmacist prescribing policies are needed. It will also aid future work in identifying the reasons why the policy may be impacting various groups differently.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
537082
Name
Chan Fiona K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Canada Postdoctoral Research Award - B
Projecttitle
Measuring the impact of pharmacist minor ailments prescribing policy on health system burden
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Health Equity; Health Services Research; Interrupted Time Series; Observational Study; Pharmacy Services; Primary Care
Abstract
The current challenges across the country in accessing a family physician have resulted in overcrowded emergency departments and delays in care. The new Pharmacist Prescribing for Minor Ailments and Contraception policy (PPMAC) in British Columbia (BC) was implemented to ease pressures on the province's healthcare system. However, even though similar policies have been in use for about ten years in some provinces, the impact of these services on the health system has never been measured. The policy may also improve equitable access to care, but prior studies have suggested that individuals experiencing socioeconomic disadvantages have less access to pharmacist services. This may worsen pre-existing health inequalities among these disadvantaged groups, which include women, rural residents, visible minority groups, lower income individuals, among others. As such, it would be important to understand 1) what the impact of the PPMAC policy is on health system burden and 2) if the level of impact differs across socioeconomic groups.
This research will describe changes in medication use, physician visits, and emergency room visits after PPMAC was implemented to understand how the policy is impacting the health system. The impact will be assessed in the three most commonly treated PPMAC conditions - contraception, urinary tract infections, and pink eye. The changes will be described by each condition for the overall population, then for various socioeconomic groups to understand if the level of impact is different across communities. We will check these findings with another study to make sure that other efforts to improve care access following the COVID-19 pandemic did not affect the results.
Findings from this work will allow policymakers in BC and other provinces to make informed decision on whether changes to pharmacist prescribing policies are needed. It will also aid future work in identifying the reasons why the policy may be impacting various groups differently.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chan, Fiona K
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~